pareptide: synthetic analog of MIF; RN given refers to (D-Leu)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10086055 |
| CHEMBL ID | 2111011 |
| SCHEMBL ID | 1369570 |
| MeSH ID | M0082948 |
| Synonym |
|---|
| ay-24856 |
| pareptide |
| pareptide [inn] |
| pareptida [inn-spanish] |
| pareptidum |
| unii-4743xi19ry |
| pareptidum [inn-latin] |
| glycinamide, l-prolyl-n-methyl-d-leucyl- |
| pareptida |
| 4743xi19ry , |
| SCHEMBL1369570 |
| n-(d-1-((carbamoylmethyl)carbamoyl)-3-methylbutyl)-n-methyl-l-2-pyrrolidinecarboxamide |
| CHEMBL2111011 |
| Q27259005 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||